Welcome to our dedicated page for Clarivate Plc SEC filings (Ticker: CLVT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Clarivate Plc (NYSE: CLVT), a company incorporated in Jersey, Channel Islands and described as a leading global provider of transformative intelligence. Through these filings, investors and analysts can review how Clarivate reports on its financial performance, capital structure and key corporate events related to its activities in Academia & Government, Intellectual Property and Life Sciences & Healthcare.
Clarivate uses Form 8-K to disclose material events, including quarterly earnings announcements and supplemental information on revenue, earnings and guidance. These filings typically reference press releases and investor presentations that are made available through the company’s investor relations channels. Other 8-K filings cover topics such as amendments to the company’s credit agreement, which detail changes to revolving credit commitments and related terms, and updates on leadership transitions or board changes.
By reviewing Clarivate’s SEC filings, users can track how the company finances its operations, including the use of revolving credit facilities, and how it communicates significant developments to the market. Filings also confirm corporate details such as Clarivate’s jurisdiction of incorporation, references to offices in London, United Kingdom, and its registration under Commission File Number 001-38911.
On Stock Titan, these documents are updated as they are posted to the SEC’s EDGAR system. AI-powered tools can help summarize lengthy filings, highlight key sections and surface items such as earnings disclosures, material agreements and governance changes, allowing users to understand the implications of Clarivate’s regulatory reporting more quickly and efficiently.
Clarivate plc reported an equity compensation transaction for a board member serving as a director. On 12/31/2025, the director received 8,607 ordinary shares, elected in lieu of a $28,750 cash retainer for Board of Directors service, based on a closing share price of $3.34 under the Clarivate plc Amended and Restated 2019 Incentive Award Plan. On the same date, 243 shares were withheld to cover taxes, also at $3.34 per share. After these transactions, the director beneficially owned 229,522 ordinary shares directly and 49,750 ordinary shares indirectly through the Jane Okun Bomba Trust U/A DTD 12/20/2018.
Clarivate plc executive share sale reported
A Clarivate plc officer, listed as President, A&G, reported selling 309,902 ordinary shares of CLVT on December 1, 2025. The transaction was coded as a sale and executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 5, 2025. The weighted average sale price was $3.74 per share, with individual sale prices ranging from $3.71 to $3.78.
After this transaction, the reporting person directly beneficially owns 848,811 ordinary shares of Clarivate. The filer notes they can provide details on the number of shares sold at each price within the stated range upon request.
A shareholder of Clarivate (CLVT) has filed a Form 144 notice to sell up to 309,902 shares of common stock. The proposed sale, to be executed through Morgan Stanley Smith Barney LLC on the NYSE, has an aggregate market value of $1,160,273.09. The filing lists an approximate sale date of 12/01/2025. The shares come from restricted stock acquired from the issuer on 03/01/2025 and 05/01/2025 in amounts of 37,793 and 272,109 shares, respectively, and are being sold against a total of 661,435,069 shares outstanding.
Clarivate plc insider reports routine share withholding for taxes. A senior officer of Clarivate plc (CLVT), serving as Senior VP, Finance and Chief Accounting Officer, reported a Form 4 transaction dated 11/15/2025. The filing shows that 50,520 ordinary shares were disposed of at a price of $3.46 per share, identified as shares withheld to cover taxes due upon the vesting of restricted share units. After this tax-related withholding, the reporting person directly held 494,171 ordinary shares of Clarivate.
Clarivate PLC (CLVT) director reported an open‑market purchase of 100,000 Ordinary Shares on 11/10/2025 at a weighted average price of $3.45, with trade prices ranging from $3.44 to $3.50.
Following the transaction, the reporting person beneficially owns 1,100,000 shares indirectly through Cornick Family Investor, LLC and 32,711 shares directly. Cornick Family Investor, LLC is controlled by Mr. Cornick and his spouse.
Clarivate Plc filed a shelf registration on Form S-3 that includes the potential primary offering of various securities and the resale, from time to time, of up to 245,076,317 ordinary shares by certain selling shareholders. These holders received shares in prior transactions, including the ProQuest (December 2021), CPA Global (October 2020), Decision Resources Group (February 2020) deals, and the 2019 merger with Churchill Capital Corp.
The company may offer ordinary shares, preferred shares, debt securities, warrants, purchase contracts, and units via future supplements. Clarivate will not receive proceeds from selling shareholder resales; proceeds from any primary issuances would be for general corporate purposes. Ordinary shares are listed on NYSE as “CLVT,” last reported at $3.54 on November 3, 2025. As context, 661,435,069 ordinary shares were outstanding as of September 30, 2025. Investors are directed to risk factors incorporated by reference from the 2024 Form 10-K and subsequent filings.
Clarivate plc (CLVT) insider activity: A director reported open‑market purchases of Ordinary Shares through Cornick Family Investor, LLC. On
Following these trades, 1,000,000 shares were beneficially owned indirectly via Cornick Family Investor, LLC, and 32,711 shares were held directly. The filing notes the LLC is controlled by Mr. Cornick and his spouse, who have voting and dispositive control over its shares.
Clarivate plc (CLVT): Director transaction disclosed. Andrew M. Snyder reported purchasing 1,460,000 ordinary shares on 10/31/2025 at a weighted average price of $3.33. The filing notes the trade prices ranged from $3.25 to $3.40, with full breakdowns available upon request.
Following the transaction, Snyder reported beneficial ownership across multiple accounts: 2,247,510 shares indirectly through Cambridge Information Group I LLC; 177,451 shares held directly; 10,489,466 shares indirectly through Cambridge Information Group II LLC; 4,033,271 shares indirectly through Cambridge Information Group III LLC; 8,821,984 shares indirectly through Cambridge Information Group Inc.; 3,417 shares indirectly through CSA GP Corporation; and 238,500 shares indirectly through the Snyder 2011 Family Trust. He disclaims beneficial ownership except to the extent of his pecuniary interest.
Clarivate (CLVT) reported Q3 2025 results with revenue of $623.1 million, essentially flat year over year. Income from operations improved to $44.0 million from $21.7 million as cost controls offset higher depreciation and amortization. Net loss narrowed to $28.3 million from $65.6 million, and interest expense declined to $68.5 million from $72.2 million.
Year to date, revenue was $1,838.2 million versus $1,893.7 million, reflecting divestitures and product wind-downs. Segment Adjusted EBITDA totaled $252.4 million in the quarter. Operating cash flow reached $468.6 million for the nine months, supporting capital expenditures of $192.5 million and share repurchases of $149.5 million for approximately 34.8 million shares. Long-term debt was $4,419.0 million, down from $4,518.7 million, aided by redeeming $600.0 million of 2026 senior secured notes and adding a $500.0 million Tranche 2 term loan. Ordinary shares outstanding were 661,435,069 as of September 30, 2025.
Clarivate Plc furnished an update on operations by releasing its earnings press release for the third quarter ended September 30, 2025. The company made the press release available as Exhibit 99.1 and posted it on its investor relations website.
The company also furnished supplemental materials covering revenue, earnings, and guidance as Exhibit 99.2, likewise posted on its investor relations site. The materials in Items 2.02 and 7.01 are being furnished and are not deemed filed under the Exchange Act.